|
A cancer organogram test as a guide for oncology treatments in SOLID tumors: An analysis of 628 tests in 419 patients. |
|
|
Employment - Sengine precision medicine |
Leadership - Sengine precision medicine |
Stock and Other Ownership Interests - Sengine precision medicine |
|
|
Employment - SEngine Precision Medicine; University of Washington |
|
|
Employment - Sengine precision medicine |
Stock and Other Ownership Interests - Sengine precision medicine |
|
|
Employment - Sengine precision medicine |
Stock and Other Ownership Interests - Moderna Therapeutics (I); Sengine precision medicine |
|
|
Employment - SEngine Precision Medicine |
|
|
Employment - Sengine precision medicine |
|
|
Employment - Sengine Precision Medicine |
Stock and Other Ownership Interests - Sengine precision medicine |
|
|
Employment - Sengine Precision Oncology |
|
|
Employment - Sengine precision medicine |
|
|
Employment - SEngine Precision Medicine |
Stock and Other Ownership Interests - SEngine Precision Medicine |
Patents, Royalties, Other Intellectual Property - Cell response assays for lung cancer. |
|
|
Employment - Sengine precision medicine |
|
|
Employment - Scisco Genetics; Sengine precision medicine; Thermo Fisher Scientific (I) |
Stock and Other Ownership Interests - Sengine precision medicine; Thermo Fisher Scientific (I) |
|
|
Employment - Applied Medical (I) |
(OPTIONAL) Uncompensated Relationships - Natera; SEngine Precision Medicine |
|
|
No Relationships to Disclose |
|
|
Employment - Elsevier; Lilly (I); UpToDate |
|
|
|
|
|
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Exelixis; Neo Therma; QED therapeutics; Zymeworks |
Research Funding - Agios (Inst); ArQule (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); BTG (Inst); Exelixis (Inst); Halozyme (Inst); MedImmune (Inst); Merck (Inst) |
Travel, Accommodations, Expenses - Eisai |
|
|
Leadership - IDEAYA Biosciences |
|
|
Leadership - SEngine Precision Medicine |
Stock and Other Ownership Interests - 3rdEyeBio; New Equilibrium Biosciences; Novilla; Sengine precision medicine |
Consulting or Advisory Role - Novartis; Puma Biotechnology; Sanofi; Seagen |
Speakers' Bureau - bioTheranostics; Seagen |
Research Funding - Agendia; Genentech/Roche (Inst); SignalOne Bio |
Travel, Accommodations, Expenses - Novartis |
|
|
Employment - Sengine precision medicine |
Leadership - Sengine precision medicine |
Stock and Other Ownership Interests - Sengine precision medicine |
Patents, Royalties, Other Intellectual Property - Sengine precision medicine |